BOSTON, June 4, 2026 /PRNewswire/ -- HotSpot Therapeutics, Inc., a biotechnology company pioneering the discovery and development of oral, allosteric small molecules that target...
YANTAI, China, Aug. 15, 2025 /PRNewswire/ -- When darkness blankets the forest and human vision fades, conservationists face a critical challenge: how to conduct...
NEW YORK, July 31, 2025 /CNW/ - GK8 by Galaxy, a leading institutional-grade digital asset custody platform, is expanding its secure decentralized finance (DeFi)...
SOUTHAMPTON, England, July 30, 2025 /PRNewswire/ -- MODERNISED (NIHR207538), a multi-site UK clinical study has passed a key milestone: over 450 participants have joined the...
SOUTHAMPTON, England, July 30, 2025 /PRNewswire/ -- MODERNISED (NIHR207538), a multi-site UK clinical study has passed a key milestone: over 450 participants have joined the...
NGET Program Phase 2 Will Focus on Enhancing Power Capabilities and Noise Reduction in Combat Vehicles
INDIANAPOLIS, July 22, 2025 /PRNewswire/ -- Allison Transmission, a...
In the independent blinded validation study, Merlin accurately identifies melanoma patients at low risk of metastatic disease, including sentinel lymph node metastasis The potential SLNB surgery...
In the independent blinded validation study, Merlin accurately identifies melanoma patients at low risk of metastatic disease, including sentinel lymph node metastasis The potential SLNB surgery...